Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



Molecular Dynamic Simulation of Centella asiatica Compound as an Inhibitor of Advanced Glycation End Products

Lili Legiawati, Fadilah Fadilah, Kusmarinah Bramono, Siti Setiati, Em Yunir.




Abstract
Cited by 2 Articles

The studies have suggested that advanced glycation end products (AGEs) induce stress oxidative and inflammatory pathway, which results in chronic complication. Centella asiatica (CA) has been shown as a promising candidate for AGE inhibitor due to its ability of reducing AGE production. This study aims to explore the molecular docking of CA active compound as an inhibitor of AGEs and receptor AGEs (RAGEs). The top three docking structures were picked for molecular dynamic (MD) simulations. Based on MD simulation in this study, we found that CA active compound had been proven to interact with AGEs and RAGE. AGEs bound to asiaticoside, madasiatic acid, and madecassic acid with a binding energy of −11.8253, −10.6724, and −10.1462 kcal/mol, respectively. Nonetheless, Asn106, Asp324, Asp376, Tyr420, and Tyr500 of AGEs made a significant contribution to the complex of asiaticoside AGE, as well as those for the madasiatic acid AGE, which were Asn118 and Tyr500. RAGE bound to asiaticoside, siatic acid, and isothankunik acid with a binding energy of −10.6125, −9.4469, and −9.1015 kcal/mol, respectively. CA active compounds, specifically asiatic acid, madasiatic acid, and madecassic acid, interacted with AGEs, whereas asiaticoside and isothankunik acid interacted with RAGE based on docking and model studies.

Key words: In silico, Centella asiatica, AGEs, RAGE






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.